Controlling the STING pathway to improve immunotherapy

Affiliations

• ¹ Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA. john.t.wilson@vanderbilt.edu.
• ² Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA. john.t.wilson@vanderbilt.edu.
• ³ Department of Pathology, Immunology, and Microbiology, Vanderbilt University, Nashville, TN, USA. john.t.wilson@vanderbilt.edu.
• ⁴ Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. john.t.wilson@vanderbilt.edu.